| Value | ₹14,712 Cr |
|---|
BSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,304.00
- Market cap
- ₹63,417 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 29.4×Sector 48.6×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Merger & Restructuring Worth ₹9.56 Cr
Alkem incorporated a Saudi Arabian joint venture subsidiary, Alkem Pharma Company LLC, on 8 November 2026. It holds 51% after subscribing SAR 38.25 lakh, about ₹9.56 Crore.
- Value
- ₹9.56 Cr
Alkem Laboratories Board Meeting Date
Alkem Laboratories has scheduled its Board meeting for 12 Nov 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Alkem Laboratories Management Change
Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Other results update announcements
All →South West Pinnacle Exploration Results Update
South West Pinnacle Exploration reported H1 FY27 revenue of Rs.1194 Mn (up 16% YoY) and PAT of Rs.133 Mn (up 23%), with a record order book of INR 7,671 Mn. The release also highlights Jharkhand coal block progress and Oman JVs.
- Order book
- ₹767.1 Cr
Mukka Proteins Results Update
Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.
- Oman facility manufacturing capacity
- 37200.0 MTPA
Aztec Fluids & Machinery Results Update
Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.
Ramky Infrastructure Results Update
Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.
Striders Impex Results Update
Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.
Jaro Institute of Technology Management and Research Results Update
Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.